RRS® Silisorg HA – Skin strengthening with silicon and hyaluronic acid
RRS® Silisorg HA is a mesotherapy treatment that combines organic silicon (methylsilanol mannuronate) with non-cross-linked hyaluronic acid. The product is developed to strengthen connective tissue, deeply hydrate the skin and stimulate tissue regeneration.
The unique combination of silicon and hyaluronic acid makes the treatment particularly effective for skin that has lost both its elasticity and moisture balance, and it is often used in areas with skin laxity and loss of structure.
What is RRS® Silisorg HA?
RRS® Silisorg HA contains:
Organic silicon – stimulates fibroblasts and increases collagen and elastin production
Hyaluronic acid – intensely moisturizes and improves skin elasticity
Antioxidants and bioactive substances – protect against oxidative stress and support cell renewal
The product is non-bulking and focuses on improving skin quality, structure and firmness.
Areas of use
-Skin laxity on the face, neck, arms, stomach or thighs
-Aged or dehydrated skin that has lost elasticity
-Skin that has lost firmness after weight changes or sun damage
-Complement to other aesthetic treatments to enhance the result
How is the treatment done?
Takes about 20–30 minutes
Injected superficially into the skin with a thin needle or cannula
Recommended course: 4–6 treatments with 1–2 week intervals
Results: gradually improved firmness, hydration and skin quality within a few weeks
The effect can be maintained with maintenance treatments
Side effects and safety
RRS® Silisorg HA is CE marked and has a high safety profile. Possible mild, transient reactions include:
-Redness
-Small bruises
-Slight swelling or tenderness
Symptoms usually subside within 1–3 days.
Benefits of RRS® Silisorg HA
✔ Combines silicon and hyaluronic acid for a double effect
✔ Strengthens the skin's structure and deeply moisturizes
✔ Stimulates fibroblasts and collagen production
✔ Improves elasticity and firmness in several areas
✔ Complements other aesthetic treatments
✔ Safe, CE-marked and clinically documented treatment